← Leaderboards
John Friend
Cellectar Biosciences, Inc.
$381,540
Attributed
$763,080
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$763,080 · 1
By mechanism
R44$763,080 · 1
Top collaborators
- Jarrod Longcor1 shared
Most similar at Cellectar Biosciences, Inc.
Same institution · by research overlap
- Jarrod Longcor$1,997,244
- Laurence Reilly$1,615,704
Others in their field
Other Emerging Leaders on “Analog”
- John Hobbs · Suny At Stony Brook$41,239,084
- Christopher Bee · Suny At Stony Brook$41,239,084
- John Damon Chodera · Sloan-Kettering Inst Can Research$15,023,002
- Jeffrey Reich · Sparian Biosciences, Inc.$14,845,721
- Thomas Dick · Rbhs-New Jersey Medical School$14,469,725
- Terry Roemer · Prokaryotics, Inc.$14,198,753
Research focus
AnalogAnti-Cd20AwardBaseB-Cell Nonhodgkins LymphomaB-LymphocytesB Lymphoid MalignancyBone Marrow BiopsyBone Marrow InvolvementCancer CellCancer TypeCause Of DeathCell ProliferationCell SurvivalChronicClinical DevelopmentClinical Trial Protocol DocumentClinical TrialsCohortDiagnosisDisease ProgressionDoseDrug UtilizationAgammaglobulinaemia Tyrosine Kinase